Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alto Neuroscience (ANRO) Return on Capital Employed (2024 - 2026)

Alto Neuroscience has reported Return on Capital Employed over the past 3 years, most recently at 35.81% for Q1 2026.

  • Quarterly results put Return on Capital Employed at 35.81% for Q1 2026, up 593.0% from a year ago — trailing twelve months through Mar 2026 was 35.81% (up 593.0% YoY), and the annual figure for FY2025 was 39.09%, up 1712.0%.
  • Return on Capital Employed reached 35.81% in Q1 2026 per ANRO's latest filing, up from 42.95% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 27.97% in Q2 2024 and bottomed at 46.24% in Q3 2025.
  • Median Return on Capital Employed over the past 3 years was 39.3% (2024), compared with a mean of 38.45%.
  • The largest annual shift saw Return on Capital Employed crashed -1683bps in 2025 before it soared 593bps in 2026.
  • Over 3 years, Return on Capital Employed stood at 39.3% in 2024, then dropped by -9bps to 42.95% in 2025, then grew by 17bps to 35.81% in 2026.
  • Business Quant data shows Return on Capital Employed for ANRO at 35.81% in Q1 2026, 42.95% in Q4 2025, and 46.24% in Q3 2025.